Position in BIIB
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$6,803,513
+$727,407 QoQ
Shares Held
31,489
-5.0% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.87%
of 13F equity value
Holder Rank
#220
of 1,031 holders
Holding Since
Mar 2020
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LEUTHOLD GROUP, LLC holds $50,589,532 across 8 Drug Manufacturers - General names. BIIB ranks #3 (13.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
31,085 | $7,894,657 | |
| 2 | AMGN |
Amgen Inc
|
20,512 | $7,427,805 | |
| 3 | BIIB |
Biogen Inc.
This page
|
31,489 | $6,803,513 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
53,031 | $6,699,936 | |
| 5 | MRK |
Merck & Co., Inc.
|
47,803 | $6,142,685 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
97,869 | $5,639,211 | |
| 7 | GSK |
GSK plc
|
97,182 | $5,094,280 | |
| 8 | PFE |
Pfizer Inc
|
202,967 | $4,887,445 |
All Filings in BIIB
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,803,513 | 31,489 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $6,076,106 | 33,143 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $5,735,338 | 32,589 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $3,294,261 | 23,517 | Shares | Sole | 2025-11-06 | |
| 2020-12-31 | $2,536,259 | 10,358 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $4,436,187 | 15,638 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $4,400,929 | 16,449 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $5,172,813 | 16,350 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||